Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06015776

Purinergic Signaling and the Postmenopausal Heart

Sponsor: Beth Israel Deaconess Medical Center

View on ClinicalTrials.gov

Summary

There is an increased risk of diastolic heart failure in post menopausal women. Estrogen plays a positive role in regulating molecular pathways in heart remodeling. Such pathways may work through purinergic signaling and its downstream effects on the heart's mitochondrial metabolism and angiogenic response to stress. Loss of estrogen functionality in post menopausal women may account for the increased risk of diastolic heart failure. The investigators will explore said pathways using cardiac tissue obtained from patients undergoing cardiac surgery.

Official title: PGC-1, Purines and the Postmenopausal Heart

Key Details

Gender

All

Age Range

30 Years - 88 Years

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2019-07-01

Completion Date

2030-06

Last Updated

2026-03-20

Healthy Volunteers

No

Interventions

OTHER

Gender

Differences between men and women will be observed

Locations (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States